ClinicalTrials.govpublic full text
Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
lung cancer non-small cell cancer (nsclc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 253010
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.